β-Lactamyl vasopressin V1a Antagonists
US7119083B2 · kind B2 · utility
11Cited by
3References
70Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2002 |
| Grant date | Oct 10, 2006 |
| Priority date | — |
| Expiry date | Oct 11, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.